New oral anticoagulants for atrial fibrillation (Q26849452)

scientific article

Language	Label	Description	Also known as
English	New oral anticoagulants for atrial fibrillation	scientific article

Statements

instance of

1 reference

New oral anticoagulants for atrial fibrillation (English)

1 reference

0 references

1 reference

1 reference

S. A. Spinler

1

1 reference

stated in

Crossref

V. Shafir

series ordinal

2

1 reference

stated in

Crossref

language of work or name

1 reference

3 July 2012

1 reference

1 reference

126

1 reference

stated in

PubMed

issue

1

1 reference

stated in

PubMed

page(s)

133-7

1 reference

stated in

PubMed

cites work

Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of anticoagulation control in atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Newly identified events in the RE-LY trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A Patient's Guide to Taking Dabigatran Etexilate

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1161%2FCIRCULATIONAHA.112.099283

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1161/CIRCULATIONAHA.112.099283

1 reference

stated in

PubMed

PubMed publication ID

22753535

1 reference

stated in

PubMed

New oral anticoagulants for atrial fibrillation (Q26849452)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

New oral anticoagulants for atrial fibrillation (Q26849452)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search